Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06693778 · ClinicalTrials.gov registry record
Utilizing Electronic Clinical Decision Support to Enhance mTBI Care at the Primary Care Point of Entry
A clinical trial of Mild Traumatic Brain Injury and Brain Concussion, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT06693778: Recruiting study of Mild Traumatic Brain Injury and Brain Concussion, sponsored by Children's Hospital of Philadelphia.
NCT06693778 is a study of Mild Traumatic Brain Injury and Brain Concussion that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 3,000 participants, above the 151-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (1887% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06693778, a study of Mild Traumatic Brain Injury and Brain Concussion, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Six primary care practices within a large Philadelphia pediatric care network will use an electronic Clinical Decision Support (eCDS) tool as standard care for concussion evaluation. The eCDS tool will include a prediction rule for children aged 5-18 assessed for mild traumatic brain injury (mTBI). The eCDS tool predicts risk for persistent symptoms and prompts referral to specialty care for those deemed high risk. This research proposes to analyze the clinical and process outcomes in these six practices relative to the rest of the care network, specifically, whether the eCDS tool reduces time to symptom resolution.
Primary Outcome
Review of medical records to determine first and last visit dates for the purposes of calculating number of days in care
Conditions Studied
Interventions
- OTHER electronic Clinical Decision Support tool for risk stratification of pediatric patients with mTBI
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2026-06 |
What NCT06693778 shows while recruiting
NCT06693778 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 151-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (1887% higher).
The record links to 2 conditions, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which electronic Clinical Decision Support tool for risk stratification of pediatric patients with mTBI is the first listed.
NCT06693778 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06693778 about?
NCT06693778 is a clinical study titled "Utilizing Electronic Clinical Decision Support to Enhance mTBI Care at the Primary Care Point of Entry". Six primary care practices within a large Philadelphia pediatric care network will use an electronic Clinical Decision Support (eCDS) tool as standard care for concussion evaluation. The eCDS tool will include a prediction rule for children aged 5-18 assessed for mild traumatic brain injury (mTBI). ...
What is the current status of trial NCT06693778?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2023-04-01. Estimated completion is 2026-06.
What conditions does trial NCT06693778 study?
This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Brain Concussion.
What interventions are being tested in trial NCT06693778?
The interventions under investigation include: electronic Clinical Decision Support tool for risk stratification of pediatric patients with mTBI (OTHER).
Who is sponsoring clinical trial NCT06693778?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06693778 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06693778's enrollment target sits among peer trials
3,000 1st of 43 higher than 43 of 43 other Mild Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI
RECRUITING · NA
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Risk Stratification in Children With Concussion
RECRUITING
-
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
RECRUITING · NA
-
Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI